ArticleCase reports in pediatrics2026
Delayed Diagnosis of Pulmonary-Renal Syndrome Presenting as Chronic Hemoptysis Leading to ESRD.
Article in Case reports in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Delayed Diagnosis of Pulmonary-Renal Syndrome Presenting as Chronic Hemoptysis Leading to ESRD.Case reports in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case demonstrates the importance of recognizing the various presentations of MPA in pediatric patients and highlights the need for more documentation and discussion of MPA in the current literature in order to increase awareness of MPA and provide possible basis for future diagnostic criteria. MPA is known to primarily affect the kidneys and present with a variety of symptoms. Though pulmonary involvement is reported in some cases of MPA, it typically does not produce overt symptoms. In our case, chronic hemoptysis was the primary presentation of our patient's MPA, which introduces a unique consideration for clinical diagnosis. This atypical presentation led to a delay in diagnosis, which allowed our patient's disease to progress to ESRD. As more cases of MPA arise, it is essential to consider their presentations in order to assess and possibly formulate future diagnostic criteria which may help allow physicians to diagnose this condition earlier and avoid life-long complications in the pediatric population.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.